Public Views on Prescription Drug Costs: Regulation, Affordability and TrumpRx
(Authors: Audrey Kearney, Alex Montero, Julian Montalvo III, Isabelle Valdes, Ashley Kirzinger, and Liz Hamel for The Kaiser Family Foundation
Read More(Authors: Audrey Kearney, Alex Montero, Julian Montalvo III, Isabelle Valdes, Ashley Kirzinger, and Liz Hamel for The Kaiser Family Foundation
Read More(By: Erica Cerutti for Becker’s Hospital Review) Cost-related medication nonadherence declined among Medicare enrollees following implementation of the Inflation Reduction
Read More(By: Elizabeth Casolo for Becker’s Hospital Review) The Republican-controlled House Committee on Energy and Commerce sent letters March 3 to ten
Read More(Authors: Sammy Cervantes and Jennifer Tolbert for The Kaiser Family Foundation Published: Mar 5, 2026) Passage of the 2025 reconciliation
Read More(By: Jakob Emerson for Becker’s Hospital Review) State Medicaid budgets will shrink by $664 billion through 2034 as key provisions
Read More(By: Jakob Emerson for Becker’s Hospital Review) The Alabama Senate has passed legislation that would impose new requirements on insurers that
Read More(Authors: Juliette Cubanski and Nolan Sroczynski for The Kaiser Family Foundation Published: Feb 11, 2026) The Medicare Drug Price Negotiation
Read More(By: Madeline Ashley for Becker’s Hospital Review) President Donald Trump signed the Labor, Health and Human Services, Education and Related
Read More(By: Madeline Ashley and Erica Cerutti for Becker’s Hospital Review) A partial government shutdown took effect Jan. 31 after Congress
Read More(By Renuka Rayasam for KFF Health News) Health policy changes in Washington will ripple through the country, resulting in millions
Read More